---
title: "Johnson &amp; Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates"
date: "2025-02-12 20:11:57"
summary: "Johnson &amp; Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ongoing efforts to refine its medtech division."
categories:
  - "benzinga"
lang:
  - "en"
translations:
  - "en"
tags:
  - "benzinga"
menu: ""
thumbnail: "https://www.benzinga.com/files/images/story/2025/02/12/Santa-Clara--Ca--Usa---Apr-29--2022-John.jpeg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ongoing efforts to refine its medtech division.

[benzinga](https://www.benzinga.com/general/biotech/25/02/43653157/johnson-johnson-explores-sale-of-stroke-device-maker-cerenovus-as-medtech-overhaul-accelerates)
